Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Ketorolac Tromethamine 0.4% and Nepafenac 0.1% for the Prevention of Cystoid Macular Edema After Phacoemulsification: Prospective Randomized Double-masked Study

NCT02084576 is registered in ClinicalTrials.gov with Hospital Oftalmologico de Brasilia as lead sponsor.

NCT NCT02084576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02084576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Ketorolac Tromethamine 0.4% and Nepafenac 0.1% for the Prevention of Cystoid Macular Edema After Phacoemulsification: Prospective Randomized Double-masked Study
Lead sponsor
Hospital Oftalmologico de Brasilia
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2013
Completion date
February 28, 2014
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract, cystoid macular edema